NKF(SH:603707) Shang Hai Zheng Quan Bao·2025-07-02 19:14Group 1 - The company, Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd., has announced a share buyback plan approved by its board and shareholders, with a total buyback amount between RMB 20 million and RMB 40 million, and a maximum price of RMB 18.75 per share [2] - The buyback is intended for employee stock ownership plans or equity incentives, with a buyback period of 12 months from the approval date [2] - As of June 30, 2025, the company has repurchased 880,000 shares, accounting for 0.05% of the total share capital, with a total expenditure of RMB 10.2207 million, excluding transaction fees and stamp duty [3] Group 2 - The company will adhere to relevant regulations and guidelines during the buyback period and will make decisions based on market conditions while fulfilling information disclosure obligations [5]